PYX Resources: Achieving volume and diversification milestones. Watch the video here.
I used to disparage any conspiracy theories about Iclaprim, as did many other sensible posters (eg Ivy) but, after the last couple of years if this, you have to wonder. A short summary: things were going well until the NASDAQ float,. then we had all sorts of mysterious dealings such that even well-informed commentators, such as "Jimbo" had to admit to not having a clue to what was going on, even after the "greenshoes" business came into our sphere of knowledge. If anything, the weirdness of trading has become worse. Then we need to have an explanation for Scott, plugging away every day. He could be shorting but I suspect a shorter would have made so much he could have cashed in any time over the past year and bought his citizenship to Malta with small change. So perhaps he is an accumulator or working for an accumulator who knows how this will pan out? I can't see anything credible in any other interpretation - anger with the BoD, no..... no-one in finance is that silly. Then, a few months ago, I started reading about ulterior motives within the FDA and the mechanisms it uses to review applications - and I began to have doubts about its probity. There are lots of sources out there, some of them as crazy as blaming Yovanovitch for Black Hawk Down, but I reference what seems to be a sober one below. The take-home message, I conclude, is that cash can influence, in ways that would be very difficult for the authorities to "prove", the approval of a drug or, even more easily, the timing of that approval. There's a mountain of cash to be made here by the obvious manipulation that could theoretically have been performed here and, given Trump's USA, the steps that needed to be taken are hardly the stuff of a John Le Carre labrynth. Of course, it's just a possibility, and I'm not signing up for the Area 51 package deal as yet, but it's one of the reasons I am holding on until the fat lady sings (or the Ukranian squeals):
https://www.sciencemag.org/news/2018/07/hidden-conflicts-pharma-payments-fda-advisers-after-drug-approvals-spark-ethical
That means nothing to a privately educated, city broker, man-of-the-people. Cash is king.
I suspect Scott might be Mr Farage.
Just realised, thanks to Professor Lawson, that, judging by his last visit to the Elysee Palace, our esteemed prime minister must, among his many other accomplishments, also have the Horn under his belt. Who knew?
A very useful addition to this thread .... compared to some. But which foot?
Yes, like sailing round the Horn with the trades on our stern - no turning back. Avast me hearties, we win or we dance the hempen jig.
" .... or the person I am getting my c**k wet with, "
I'm guessing "Ni*el Fa*ag*??? ;-)
Never, never end a sentence with a preposition.
Nothing much happening and positive vibes would send it crashing. Hope that helps.
Eternal vigilance is the price we have to pay ....
If it's a noun, I'm buying some.
AS I've said before, if trial design was at fault then it's the immediate responsibility and fault of the CRO. Of course the BOD should question the CRO hard but, without real statistical expertise, that's not going to be easy. Both at fault here but it's good, if that's the case, to see the trail designers admit to being in error (of course they won't publicly) ... or perhaps they knew they would never get paid anyway! As for the paperboy, I don't really buy the argument. As ivy points out, I'm not sure the protocol would have been given approval if there were serious doubts in that direction and, secondly, this criticism is a little bit like saying that a cancer trial is not fair because they chose only cancer patients.
Observation: all middle-class dumb people in private schools claim they are dyslexic but the working class can't afford the psychologist's report and, hence, don't get the extra exam time. So, who cares most about spelling, punctuation, and grammar?
Prefer the slipper ...
Catholic St Expedita is the one we need. (Pedant alert: No comma after St Jude Kettle although you could have one after "does" ...)
With even the slightest chance of success, and at that % loss, surely it's just not worth selling? Hold and pray I would say.
If they appoint someone appropriate to take this forward, perhaps with Haigh's caution plus Pearce's marketing abilities, this could get interesting.
Sheltie, you have to laugh - that's just like the stuff people were saying about MTFB two years ago. Plus ca change ...
I guess someone's buying them?